Manufacturer: ANTIBIOTICE SA - ROMANIA
Holder: ANTIBIOTICE SA - ROMANIA
Number: 11783/2019/02
Shelf life: 4 years
Indicated for: bacterial infections
Substance: streptomycin (aminoglycoside antibiotic)
ATC: J01GA01 (Antiinfectives for systemic use | Aminoglycoside antibacterials | Streptomycins)
Streptomycin is an aminoglycoside antibiotic used for the treatment of tuberculosis and other severe bacterial infections. It works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and multiplication.
The medication is administered intramuscularly or intravenously, as directed by a doctor. It is important for patients to complete the full course of treatment to prevent the development of bacterial resistance.
Patients should be aware of potential side effects, such as hearing loss, dizziness, or kidney dysfunction. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, nausea, and injection site reactions. In rare cases, severe reactions such as ototoxicity or nephrotoxicity may occur. Patients should be informed of these risks before starting treatment.
Manufacturer: ANTIBIOTICE SA - ROMANIA
Holder: ANTIBIOTICE SA - ROMANIA
Number: 11783/2019/02
Shelf life: 4 years